Imatron expects record 1994 revenues
CT developer Imatron is anticipating record revenues for its 1994fiscal year (end-December). The South San Francisco, CA, companysaid last week that its revenues for the year should exceed $33million, an increase of at least 31% over last year's figure
CT developer Imatron is anticipating record revenues for its 1994fiscal year (end-December). The South San Francisco, CA, companysaid last week that its revenues for the year should exceed $33million, an increase of at least 31% over last year's figure of$25.1 million. Net income for 1994 should be $2.3 million, versusa loss of $2.9 million in 1993.
Imatron has enjoyed strong sales of its C-150 Ultrafast CTscanner in recent months. Imatron received an order in Decemberfor 10 C-150 units from Imatron Japan in a transaction worth $16million (SCAN 12/28/94). Revenue from that sale will registerin the company's 1995 and 1996 fiscal years.
Imatron's backlog is at its highest level since the companywas formed in 1983, president and CEO Lewis Meyer said. The backlogshould help the firm register revenues of over $40 million in1995.
This year Imatron will embark on a major expansion of its HeartScanImaging clinics, which provide coronary artery screening directlyto the public (SCAN 4/6/94). Imatron plans to open clinics inSeattle, Houston and Washington, DC.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
